World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
69
Citations
28491
World Ranking
1992
National Ranking
36

Overview

Otto Cars is affiliated with Uppsala University in Sweden and conducts research primarily in the fields of Immunology and Microbiology as well as Medicine. Their work spans several subfields including Applied Microbiology and Biotechnology, Molecular Medicine, Pediatrics, Perinatology and Child Health, Economics and Econometrics, and Epidemiology.

The scientist's research focuses on a range of topics related to antibiotic use and resistance. These topics include:

  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Global Maternal and Child Health
  • Pharmaceutical Economics and Policy
  • Pneumonia and Respiratory Infections
  • Health Policy Implementation Science
  • Biosimilars and Bioanalytical Methods

Among recent publications by Otto Cars are:

  • Resetting the agenda for antibiotic resistance through a health systems perspective, 2021, The Lancet Global Health
  • Equitable Access to Antibiotics: A Core Element and Shared Global Responsibility for Pandemic Preparedness and Response, 2022, The Journal of Law Medicine & Ethics
  • Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation, 2023, The Lancet
  • The language of antimicrobial and antibiotic resistance is blocking global collective action, 2024, Infectious Diseases
  • The 2024 political declaration on antimicrobial resistance needs bold targets, 2024, BMJ

Their frequent coauthors include Sujith J Chandy, Mirfin Mpundu, Arturo Quizhpe Peralta, Anthony D. So, and Kerstin Åkerfeldt, each collaborating on multiple occasions.

Otto Cars's work has often appeared in recognized publication venues such as The Lancet Global Health, The Journal of Law Medicine & Ethics, Infectious Diseases, The Lancet, and BMJ.

Best Publications

  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

    Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth

  • Antibiotic resistance—the need for global solutions

    Ramanan Laxminarayan;Ramanan Laxminarayan;Ramanan Laxminarayan;Adriano Duse;Chand Wattal;Anita K. M. Zaidi

  • A European study on the relationship between antimicrobial use and antimicrobial resistance.

    Stef L.A.M. Bronzwaer;Otto Cars;Udo Buchholz;Sigvard Mölstad

  • Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli

    Christian G. Giske;Dominique L. Monnet;Otto Cars;Yehuda Carmeli;Yehuda Carmeli

  • Antimicrobial resistance is a major threat to public health

    Richard Wise;Tony Hart;Otto Cars;Marc Streulens

  • Variation in antibiotic use in the European Union

    Unknown

  • Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

    Johan W. Mouton;Michael N. Dudley;Otto Cars;Hartmut Derendorf

  • Antibiotic Resistance — Problems, Progress, and Prospects

    Carl Nathan;Otto Cars

  • Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers

    Thomas Tängdén;Otto Cars;Åsa Melhus;Elisabeth Löwdin

  • Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

    D. Plachouras;M. Karvanen;L. E. Friberg;E. Papadomichelakis

  • Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now ☆

    Laura Freire-Moran;Bo Aronsson;Chris Manz;Inge C. Gyssens;Inge C. Gyssens

  • Framework for optimisation of the clinical use of colistin and polymyxin B : the Prato polymyxin consensus

    Roger Leigh Nation;Jian Li;Otto Cars;William Couet

  • Tissue concentrations: do we ever learn?

    Johan W. Mouton;Ursula Theuretzbacher;William A. Craig;Paul M. Tulkens

  • Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme.

    Sigvard Mölstad;M Erntell;Håkan Hanberger;E Melander

  • The global need for effective antibiotics: challenges and recent advances.

    Liselotte Diaz Högberg;Andreas Heddini;Otto Cars

  • Meeting the challenge of antibiotic resistance

    Otto Cars;Liselotte Diaz Högberg;Mary Murray;Olle Nordberg

  • Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

    Ami Fazlin Syed Mohamed;Ilias Karaiskos;Diamantis Plachouras;Matti Karvanen

  • Protein binding – do we ever learn?

    Markus A. Zeitlinger;Hartmut Derendorf;Johan W. Mouton;Otto Cars

  • Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

    Elisabet I. Nielsen;Otto Cars;Lena E. Friberg

  • National campaigns to improve antibiotic use

    Herman Goossens;Didier Guillemot;Matus Ferech;Benoit Schlemmer

  • Optimizing Drug Exposure to Minimize Selection of Antibiotic Resistance

    Sara K. Olofsson;Otto Cars

Frequent Co-Authors

Ramanan Laxminarayan
Ramanan Laxminarayan Center for Disease Dynamics, Economics & Policy
Diarmaid Hughes
Diarmaid Hughes Uppsala University
Dan I. Andersson
Dan I. Andersson Uppsala University
Johan W. Mouton
Johan W. Mouton Radboud University Medical Center
Lennart Nilsson
Lennart Nilsson Karolinska Institute
Yehuda Carmeli
Yehuda Carmeli Tel Aviv University
Lars Engstrand
Lars Engstrand Karolinska Institute
Helen Giamarellou
Helen Giamarellou National and Kapodistrian University of Athens
Christian G. Giske
Christian G. Giske Karolinska University Hospital
Göran Tomson
Göran Tomson Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open diverse career opportunities for those interested in microbiology. For individuals with unique challenges, such as a criminal record, finding the best degree for felons is crucial. Many online programs offer flexible options that can help overcome barriers and create new professional paths.

Healthcare fields connected to microbiology often include roles like a functional medicine nurse practitioner programs, which combine scientific knowledge with patient-centered care. These programs provide advanced training for working in integrative and holistic health environments, expanding career options.

Another valuable certification is the certified professional coder certification, which opens doors in medical billing and coding. This certification supports accurate documentation in health services, a critical part of the healthcare industry that intersects with microbiology labs and clinical data management.

For those keen on managing medical data, pursuing a health information management degree salary offers insight into potential earnings and career growth. This pathway focuses on the organization and security of patient information, an area increasingly important as digital records become standard.

Best Scientists Citing Otto Cars

Trending Scientists